China NMPA Drug Inspection - Hunan Xiangyikang Pharmaceutical Co., Ltd. - Sodium cefamandole for injection
China NMPA drug inspection for Hunan Xiangyikang Pharmaceutical Co., Ltd. published January 13, 2016. Drug: Sodium cefamandole for injection. The State Food and Drug Administration (SFDA) announced on January 13, 2016, findings from national drug sampling inspec
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hunan Xiangyikang Pharmaceutical Co., Ltd. published January 13, 2016. Drug: Sodium cefamandole for injection. The State Food and Drug Administration (SFDA) announced on January 13, 2016, findings from national drug sampling inspec
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox